Tag

Regulation

Reporting tagged Regulation, drawn from across our six pillars.

A dim living room at night, a single warm lamp glowing beside an armchair with a folded blanket and a glass of water on a small tray.

Ketamine by Mail: What the Evidence Supports — and What the At-Home Boom Assumed

The clinic evidence for ketamine in depression is real and randomized. The booming at-home telehealth version is built on a different drug product, different doses, no head-to-head trials — and regulators have started saying so out loud.

Revuelt Health · October 20, 2026 · 10 min read

Read

A quiet still life on a pale wooden surface in soft morning light: a shallow ceramic dish holding dried seed pods, a folded length of unbleached linen, and a plain glass of water catching the window.

Chronic & Complex Illness

Fecal Transplants Beyond C. diff: What Is Approved, What Is Promising, and What Got Harder to Get

Transferring a healthy person's gut microbes into a sick person's colon is an approved, guideline-backed treatment — for exactly one condition. This year the field finally produced randomized data outside that condition, a regulator said no to the most advanced product in Europe, and a manufactured alternative matched donor stool in a head-to-head trial. None of it points the same direction.

Revuelt Health · September 15, 2026 · 13 min read

Read

An empty therapy room with two chairs facing each other in soft daylight.

Psychedelic Therapies

MDMA-Assisted Therapy After the Rejection: Where the Work Stands

A Phase 3 programme produced some of the largest effect sizes in modern psychiatry. The regulator was not persuaded — and what it objected to was not, in the main, the effect size.

Revuelt Health · August 9, 2026 · 10 min read

Read

A quiet coastal clinic room with a white linen bed and a cardiac monitor beside it

Clinics & Destinations

Inside the Ibogaine Clinics: Ambio and Beond

Two Mexican providers now anchor the clinical ibogaine world. What their protocols look like, what the Nature Medicine data showed, and where the cardiac risk actually sits.

Revuelt Health · July 22, 2026 · 11 min read

Read

Dried iboga root bark arranged on pale linen

Psychedelic Therapies

Ibogaine and the Hard Problem of Addiction: What the Research Actually Shows

Observational data on opioid withdrawal is genuinely interesting. The cardiac risk profile is genuinely serious. Both facts have to be held at once.

Revuelt Health · July 14, 2026 · 11 min read

Read

A soft beam of warm light falling across a quiet minimal room with a wooden stool

Psychedelic Therapies

Ketamine Clinics Are Multiplying. The Standard of Care Has Not Caught Up.

The drug works quickly for some people with severe depression. What happens around the infusion varies enormously from clinic to clinic.

Revuelt Health · June 9, 2026 · 7 min read

Read

Related tags

The dispatch

Join our list — new writing on the frontier of medicine, in your inbox.

Considered emails, never more than you want. Research, clinics, and what the evidence currently supports. No hype, no unsubscribing guilt.